Publicación:
Efectividad de la terapia antirretroviral de gran actividad (Targa) en pacientes VIH positivos ingresados al programa de tratamiento de la IPS atención integral en la ciudad de Cartagena, Colombia.

dc.contributor.authorTorres Mora , Gustavospa
dc.contributor.authorMoreno Grau , Álvarospa
dc.contributor.authorMoreno Hernández , Diegospa
dc.contributor.authorBerrocal Almanza , Luis Carlosspa
dc.contributor.authorRamos Clason , Enrique Carlosspa
dc.date.accessioned2021-07-12 22:26:31
dc.date.available2021-07-12 22:26:31
dc.date.issued2021-07-12
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2011-3385
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urlhttps://doi.org/10.32997/rcb-2011-3385
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3385/2867
dc.relation.citationeditionNúm. 1 , Año 2011spa
dc.relation.citationendpage53
dc.relation.citationissue1spa
dc.relation.citationstartpage44
dc.relation.citationvolume2spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesMinisterio de la Protección Social. Plan nacional de respuesta ante el VIH y el SIDA. Colombia 2008-2011 Bogotá D. C. Enero de 2008.spa
dc.relation.referencesMinisterio de la Protección Social. Guía para el manejo de VIH/SIDA basada en la evidencia Colombia. 2003.spa
dc.relation.referencesJoint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the Global AIDS Epidemic. Geneva, Switzerland: World Health Organization; 2008.spa
dc.relation.referencesCalleja JM, Walker N, Cuchi P, et al. Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. AIDS 2002;16(suppl ):S3–S12.spa
dc.relation.referencesVogel M, Schwarze-Zander C, Wasmuth JC, Spengler U, Sauerbruch T, Rockstroh JK. The treatment of patients with HIV. Dtsch Arztebl Int 2010; 107(28–29): 507–16.spa
dc.relation.referencesQuinn TC.HIV epidemiology and the effects of antiviral therapy on long-term Consequences. AIDS. 2008 ; 22(Suppl 3): S7–12.spa
dc.relation.referencesCenters for Disease Control and Prevention (CDC). AIDS surveillance – general epidemiology (through 2005) slide set. CDC; Atlanta, GA: 2007.spa
dc.relation.referencesVolberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010 ;376(9734):49-62.spa
dc.relation.referencesRay S, Fatima Z, Saxena A. Drugs for AIDS. Mini Rev Med Chem. 2010;10(2):147-61.spa
dc.relation.referencesGhosh RK, Ghosh SM, Chawla S. Recent advances in antiretroviral drugs. Expert Opin Pharmacother. 2010 Vol. 0, No. 0 :1-16.spa
dc.relation.referencesFinzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295-1300.spa
dc.relation.referencesFinzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5(5):512-517.spa
dc.relation.referencesWong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278(5341):1291-1295.spa
dc.relation.referencesPanel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1-161. Disponible en: Paterson http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Consultado en (Agosto 5 de 2010).spa
dc.relation.referencesMurray JS, Elashoff MR, Iacono-Connors LC, et al. The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS. 1999;13(7):797-804.spa
dc.relation.referencesHughes MD, Johnson VA, Hirsch MS, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med. 1997;126(12):929-938.spa
dc.relation.referencesMarschner IC, Collier AC, Coombs RW, et al. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J Infect Dis. 1998;177(1):40-47.spa
dc.relation.referencesThiébaut R, Morlat P, Jacqmin-Gadda H, et al. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d’Epidémiologie du SIDA en Aquitaine (GECSA). AIDS. 2000; 14(8):971-978.spa
dc.relation.referencesAberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(5):651-681.spa
dc.relation.referencesThompson MA, Aberg JA, Cahn P et al. Antiretroviral treatment of adult HIV Infection: 2010 Recommendations of the International AIDS Society USA Panel. JAMA. 2010;304(3):321-333.spa
dc.rightsGustavo Torres Mora - 2011spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3385spa
dc.subjectacquired immunodeficiency syndromeeng
dc.subjecthighly active antiretroviral therapyeng
dc.subjectviral loadeng
dc.subjectCD4-positive T-lymphocyteseng
dc.subjectpractice guidelineseng
dc.subjectsíndrome de inmunodeficiencia adquiridaspa
dc.subjectterapia antirretroviral altamente activaspa
dc.subjectcarga viralspa
dc.subjectlinfocitos T CD4-positivosspa
dc.subjectguías de práctica clínicaspa
dc.titleEfectividad de la terapia antirretroviral de gran actividad (Targa) en pacientes VIH positivos ingresados al programa de tratamiento de la IPS atención integral en la ciudad de Cartagena, Colombia.spa
dc.title.translatedEffectiveness of antiretroviral therapy (Haart) in HIV positive patients admitted to the treatment program of “atención integral IPS” in the city of Cartagena, Colombia.eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: